Regulating Mitochondrial pH with Light and Implications for Chemoresistance.

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Chemoresistance poses a significant challenge in cancer therapy.
• Defective mitochondrial outer membrane permeabilization (MOMP) is linked to chemoresistance by reducing apoptosis.
• Targeting mitochondrial function offers a potential strategy to overcome chemoresistance.

Purpose of the Study:

• To develop and evaluate a novel photoacid generator (BD-PAG) for targeting mitochondria.
• To investigate BD-PAG's ability to modulate mitochondrial pH and membrane potential.
• To assess the efficacy of BD-PAG in combination therapy to overcome chemoresistance.

Main Methods:

• Synthesis and characterization of a BODIPY-based triarylsulfonium photoacid generator (BD-PAG).
• Cell viability assays to assess biocompatibility and efficacy.
• Live cell imaging for mitochondrial localization.
• Mitochondrial pH and membrane potential measurements.
• Combination therapy studies with chlorambucil.

Main Results:

• BD-PAG demonstrated good biocompatibility in the dark and high accumulation in mitochondria.
• BD-PAG effectively regulated mitochondrial pH and induced mitochondrial membrane depolarization.
• Combination therapy with BD-PAG and chlorambucil showed a new strategy for suppressing chemoresistance.

Conclusions:

• BD-PAG is a promising mitochondria-targeting agent for modulating mitochondrial function.
• This approach offers a novel strategy to overcome chemoresistance in cancer treatment.
• Further research into BD-PAG-based therapies could enhance chemotherapeutic efficacy.